IMMUNE-MEDIATED HYPERTHYROIDISM

This adverse event was reported 29 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED HYPERTHYROIDISM:

# Drug Count
0 PEMBROLIZUMAB 25
1 NIVOLUMAB 10
2 IPILIMUMAB 9
3 CARBOPLATIN 6
4 PEMETREXED DISODIUM 5
5 AXITINIB 4
6 ASPIRIN 3
7 ASPIRIN 325 MG 3
8 ASPIRIN 81 MG 3
9 ASPIRIN TABLET 325MG 3
See all common drugs associated with IMMUNE-MEDIATED HYPERTHYROIDISM

IMMUNE-MEDIATED HYPERTHYROIDISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NALDEMEDINE 1 0.0011
1 PEMBROLIZUMAB 25 0.0007
2 PEMETREXED DISODIUM 5 0.0004
3 AXITINIB 4 0.0003
4 IPILIMUMAB 9 0.0003
5 ICOSAPENT ETHYL 1 0.0002
6 METHIMAZOLE 1 0.0002
7 NIVOLUMAB 10 0.0002
8 APREPITANT 2 0.0002
9 LUBIPROSTONE 1 0.0001
See all drugs enriched for association with IMMUNE-MEDIATED HYPERTHYROIDISM